Auro Laboratories Limited has informed about the Resignation of Ms. Priyanka Gupta as Company Secretary and Compliance Officer of the Company with effect from closure of working hours on ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Auro Laboratories reported weak Q1 FY26 results, with revenue from operations falling to Rs. 277.42 lakhs versus Rs. 572.04 lakhs in Q1 FY25 — a drop of about 51% year-on-year. Total income stood at Rs. 319.07 lakhs and the company swung to a loss before tax of Rs. 10.55 lakhs, compared to a profit of Rs. 100.58 lakhs in the same quarter last year. EPS turned negative at Rs. (0.17). Separately, Company Secretary and Compliance Officer Ms. Priyanka Gupta resigned citing better prospects, effective from the close of business on September 30, 2025. The statutory auditors issued an unmodified limited review report on the results.
The sharp revenue decline and swing to a quarterly loss are negatives for the stock and signal pressure on the pharma business. The Company Secretary exit is a routine KMP change with a reasonable transition period until end-September, and is unlikely to materially affect operations on its own.